Ardais Corporation

About:

Ardais Corporation, a leading clinical genomics company, is dedicated to enhancing and accelerating biomedical research.

Website: http://www.ardais.com/corporate/

Top Investors: Bessemer Venture Partners, Advent International, CIT Group, Advanced Technology Ventures, Bioventures Investors

Description:

Ardais Corporation is a clinical genomics company, is dedicated to enhancing and accelerating biomedical research by introducing actual human disease into the pharmaceutical discovery research process. To achieve its goals, Ardais has incorporated multi-disciplinary scientific expertise into its operations, including pathology, molecular biology and genomics, statistical genomics, bioinformatics and medical informatics, as well as process management skills such as logistics, industrial engineering, and robotics. The result of this unique integration is a state-of-the-art, proprietary discovery platform that is dramatically transforming genomic research and leading the way to novel diagnostic and therapeutic solutions.

Total Funding Amount:

$56.5M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

1996-04-01

Contact Email:

info(AT)ardais.com

Founders:

Alan J. Buckler, Martin L. Ferguson

Number of Employees:

1-10

Last Funding Date:

2003-01-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai